EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Effectiveness of ongoing single dose rifampicin post-exposure prophylaxis (SDR-PEP) implementation under routine programme conditions—An observational study in Nepal

Nand Lal Banstola iD, Epco Hasker, Liesbeth Mieras, Dambar Gurung, Bhuwan Baral, Suresh Mehata, Sagar Prasai, Yograj Ghimire, Brij Kumar Das, Prashnna Napit, Wim van Brakel

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012446 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Nand Lal Banstola und 10 weiteren Autor:innen. Beteiligte Einrichtung: Programme department, NLR, Biratnagar, Koshi, Nepal. Hauptthemen laut MEDLINE: Rifampin, Leprosy, Post-Exposure Prophylaxis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leprosy Research Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Introduction Leprosy control remains a challenge in Nepal. Single-dose rifampicin post-exposure prophylaxis (SDR-PEP) shows promise in reducing leprosy incidence among contacts of index cases, contributing to reducing the transmission of Mycobacterium (M . ) leprae . This study evaluates the effectiveness of routine SDR-PEP implementation in Nepal in addition to contact screening, focusing on its impact on reducing leprosy risk among contacts and potential population-level effects. Methodology We conducted a retrospective cohort study to compare leprosy case notification rates and leprosy risk among close contacts. We compared two districts implementing SDR-PEP (the intervention group) and two without (the comparator group). Data from 2015 onwards included demographics, index case types, and contact relationships. Statistical analyses, including Cox regression and Kaplan-Meier survival curves, assessed the impact of SDR-PEP implementation.

Findings

All four districts showed a decrease in case notification rates since 2015, with the steepest decline in the intervention districts. The risk of developing leprosy among contacts was significantly lower in the intervention districts (HR 0.28, 95% CI 0.18–0.44). SDR-PEP offered 72% protection, consistent over time, as shown in Kaplan-Meier plots. The protective effect was equally strong in blood-related contacts (HR 0.29 versus 0.27 in others, p = 0.32), and the proportion of MB cases among incident cases was not significantly different post-PEP (51.4% vs. 53.6%, p = 0.82).

Conclusions

This study demonstrates the substantial protective effect of integrating SDR-PEP in routine leprosy control programs with contact screening, significantly lowering leprosy risk among contacts. SDR-PEP is equally effective for blood-related contacts and does not preferentially prevent PB cases. While suggesting potential population-level impact, the study design does not allow for firm conclusions at this level. Further research is needed to fully assess SDR-PEP’s effectiveness in diverse contexts and optimize its implementation. Integrating SDR-PEP within well-organized contact screening programs is effective and is expected to reduce leprosy transmission when applied as a rolling intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinLeprosyPost-Exposure ProphylaxisHumansNepalRetrospective StudiesMaleFemaleAdultAdolescentYoung AdultChildMiddle AgedLeprostatic AgentsChild, PreschoolContact TracingIncidenceAgedInfantMycobacterium leprae

Substanzen

RifampinLeprostatic Agents

Autor:innen und Institutionen

  • Programme department, NLR, Biratnagar, Koshi, Nepal.
  • Mycobacterial Diseases and Neglected Tropical Diseases, Institute of Tropical Medicine, Antwerp, Belgium.
  • Research and Advocacy, NLR IO, Amsterdam, The Netherlands.
  • Field programme, FAIRMED, Biratnagar, Koshi, Nepal.
  • Technical department, FAIRMED, Kathmandu, Bagmati, Nepal.
  • Public Health, Health office Morang, Biratnagar, Koshi, Nepal.

ORCID-Profile: Nand Lal Banstola

Förderung

  • Leprosy Research Initiative

Zitieren

APA

Banstola, N. L., Hasker, E., Mieras, L., Gurung, D., Baral, B., Mehata, S., Prasai, S., Ghimire, Y., Das, B. K., Napit, P., & van Brakel, W. (2024). Effectiveness of ongoing single dose rifampicin post-exposure prophylaxis (SDR-PEP) implementation under routine programme conditions—An observational study in Nepal. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012446

Vancouver

Banstola NL, Hasker E, Mieras L, Gurung D, Baral B, Mehata S, et al. Effectiveness of ongoing single dose rifampicin post-exposure prophylaxis (SDR-PEP) implementation under routine programme conditions—An observational study in Nepal. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012446

BibTeX
@article{Banstola2024,
  author = {Banstola, Nand Lal and Hasker, Epco and Mieras, Liesbeth and Gurung, Dambar and Baral, Bhuwan and Mehata, Suresh and Prasai, Sagar and Ghimire, Yograj and Das, Brij Kumar and Napit, Prashnna and van Brakel, Wim},
  title = {Effectiveness of ongoing single dose rifampicin post-exposure prophylaxis (SDR-PEP) implementation under routine programme conditions—An observational study in Nepal},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012446}
}
Kostenlos starten →